China Jo-Jo Drugstores, Inc.
CJJDNASDAQHealthcare
$1.52
$-0.09(-5.59%)
Market Cap$9947169
P/E Ratio—
52W High$4.5
52W Low$0.8531
China Jo-Jo Drugstores, Inc. (CJJD) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CJJD · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-03 | 2023-03 | 2022-03 | 2021-03 | 2020-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.15B | $0.15B | $0.16B | $0.13B | $0.12B |
| Cost of Revenue | $0.12B | $0.11B | $0.13B | $0.10B | $0.09B |
| Gross Profit | $0.03B | $0.03B | $0.04B | $0.03B | $0.03B |
| Gross Margin %(computed) | 20.13% | 23.04% | 22.21% | 21.97% | 21.76% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.01B | $0.02B | $0.01B | $0.01B | $0.01B |
| Total Operating Expenses | $0.03B | $0.04B | $0.04B | $0.04B | $0.03B |
| Operating Income | ($0.00B) | ($0.01B) | ($0.00B) | ($0.01B) | ($0.01B) |
| Operating Margin %(computed) | -2.29% | -7.10% | -1.55% | -6.47% | -5.43% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.00B) | ($0.02B) | ($0.00B) | ($0.01B) | ($0.01B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.00B) | ($0.02B) | ($0.00B) | ($0.01B) | ($0.01B) |
| Net Margin %(computed) | -2.74% | -14.21% | -1.95% | -6.29% | -5.50% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.93 | $-41.46 | $-220.62 | $-49.29 | $-2.30 |
| Wtd Avg Shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| EBITDA | $0.00B | ($0.02B) | ($0.00B) | ($0.01B) | ($0.00B) |
| EBITDA Margin %(computed) | 0.79% | -13.41% | -0.35% | -4.56% | -3.12% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more China Jo-Jo Drugstores, Inc. data
About China Jo-Jo Drugstores, Inc. (CJJD) Income Statement
China Jo-Jo Drugstores, Inc. (CJJD) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, CJJD reported revenue of $0.15B, gross profit of $0.03B (gross margin 20.13%), and net income of ($0.00B) — a net profit margin of -2.74%.
Frequently asked questions
CJJD · 4 questionsChina Jo-Jo Drugstores, Inc. (CJJD) reported revenue of $0.15B for 2024, up 3.8% year-over-year.
CJJD revenueCJJD salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09